Trial Investigating the Effect of Semaglutide on Energy Intake, Appetite Sensations, Postprandial Glucose and Triglyceride Metabolism and Gastric Emptying in Obese Subjects Compared With Placebo
NCT02079870
Completed
This trial is conducted in Europe. The aim of the trial is to investigate the effect of semaglutide on energy intake, appetite sensations, postprandial glucose and triglyceride metabolism and gastric emptying in obese subjects compared with placebo.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/30/2017
Locations: Novo Nordisk Investigational Site, Leeds, Not set
Conditions: Diabetes, Metabolism and Nutrition Disorder, Obesity
Register for Updates
Pharmacoscintigraphic Investigation of NN9924 in Healthy Male Subjects
NCT01619345
Completed
This trial is conducted in Europe. The aim of this trial is to investigate whether the volume of water administered with NN9924 affects the anatomical location (stomach or proximal small bowel) of tablet erosion.
Gender:
MALE
Ages:
Between 18 years and 64 years
Trial Updated:
02/20/2015
Locations: Not set, Nottingham, Not set
Conditions: Diabetes, Healthy
Register for Updates
Safety, Tolerability, and Profile of Action of Drug in the Body of NN9535 in Healthy Male Japanese and Caucasian Subjects
NCT00851773
Completed
This trial is conducted in Europe. The aim of this clinical trial is to assess and compare the safety and tolerability, as assessed by adverse events after multiple subcutaneous doses of NN9535 in healthy male Japanese and Caucasian subjects.
Gender:
MALE
Ages:
Between 20 years and 45 years
Trial Updated:
02/20/2015
Locations: Not set, London SW, Not set
Conditions: Diabetes, Healthy
Register for Updates